Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera

被引：0
|
作者：
Mario Tiribelli
Daniela Barraco
Federico De Marchi
Luciana Marin
Marta Medeot
Daniela Damiani
Renato Fanin
机构：
[1] Azienda Ospedialiero-Universitaria di Udine,Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Acute Myeloid Leukemia; Myeloid Leukemia; Cardiovascular Risk Factor; Cumulative Incidence; Polycythemia Vera;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：873 / 874
页数：1
相关论文
共 50 条
  • [21] CLINICAL CONFERENCE - POLYCYTHEMIA RUBRA VERA
    URBAN, SY
    BRAFF, G
    SLUBOWSKI
    LIN, D
    MALCOLMSON, J
    JAVID, J
    DHALLA, S
    FLYNN, JT
    NEW YORK STATE JOURNAL OF MEDICINE, 1986, 86 (11) : 564 - 570
  • [22] Two Clinical Phenotypes in Polycythemia Vera
    Spivak, Jerry L.
    Considine, Michael
    Williams, Donna M.
    Talbot, Conover C., Jr.
    Rogers, Ophelia
    Moliterno, Alison R.
    Jie, Chunfa
    Ochs, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (09): : 808 - 817
  • [23] A Real-World Evaluation of Risk Factors for Disease Progression in Patients With Polycythemia Vera (PV): An Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices (REVEAL)
    Grunwald, Michael R.
    Zwicker, Jeffrey I.
    Gerds, Aaron T.
    Burke, John M.
    Xue, Zhenyi
    Crowgey, Erin L.
    Carl, Justine
    Feldman, Patricia
    Braunstein, Evan M.
    Oh, Stephen T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S415 - S416
  • [24] Risk factors for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
    韩雪
    China Medical Abstracts(Internal Medicine), 2019, 36 (02) : 120 - 121
  • [25] JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events
    Alvarez-Larran, Alberto
    Bellosillo, Beatriz
    Pereira, Arturo
    Kerguelen, Ana
    Carlos Hernandez-Boluda, Juan
    Martinez-Aviles, Luz
    Fernandez-Rodriguez, Concepcion
    Gomez, Montse
    Lombardia, Luis
    Angona, Anna
    Ancochea, Agueda
    Senin, Alicia
    Longaron, Raquel
    Navarro, Blanca
    Collado, Maria
    Besses, Carlos
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) : 517 - 523
  • [26] Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications
    Pourcelot, Emmanuel
    Trocme, Candice
    Mondet, Julie
    Bailly, Sebastien
    Toussaint, Bertrand
    Mossuz, Pascal
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (05) : 360 - 368
  • [27] CLINICAL CHARACTERISTICS OF POLYCYTHEMIA VERA PATIENTS, RECEIVING DIFFERENT TYPES OF THERAPY
    Shikhbabaeva, D.
    Shuvaev, V.
    Martynkevich, I.
    Abdulkadyrova, A.
    Udaleva, V.
    Zamotina, T.
    Fominykh, M.
    Golovchenko, R.
    Zotova, I.
    Polushkina, L.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2015, 100 : 541 - 541
  • [28] Arterial Stiffness as a New Predictor of Clinical Outcome in Patients with Polycythemia Vera
    Mulas, Olga
    Sestu, Alessandro
    Costa, Alessandro
    Chessa, Salvatore
    Vargiu, Carla
    Corda, Ludovica
    Pittau, Francesca
    La Nasa, Giorgio
    Caocci, Giovanni
    Scuteri, Angelo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [29] POLYCYTHEMIA VERA - LABORATORY DATA, CLINICAL COURSE AND PROGNOSIS OF 141 PATIENTS
    ANGER, B
    HAUG, U
    SEIDLER, R
    POPP, C
    HEIMPEL, H
    BLUT, 1988, 57 (04): : 230 - 230
  • [30] The Efficacy of Anticoagulant Treatment on the Evolution of Thrombotic Complications in Patients With Polycythemia Vera Syndrome
    Badulescu, O.
    Badescu, C.
    Ciocoiu, M.
    Badescu, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S642 - S642
12345